Synlogic (SYBX)
(Real Time Quote from BATS)
$1.46 USD
+0.09 (6.57%)
Updated Aug 14, 2024 01:58 PM ET
3-Hold of 5 3
F Value A Growth A Momentum B VGM
Brokerage Reports
Synlogic, Inc. [SYBX]
Reports for Purchase
Showing records 101 - 111 ( 111 total )
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
AACR Presentations Highlight I/O Pipeline; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
First Patient Dosed in SYNB1020 Phase 1/2a Hyperammonemia Trial; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
4Q and FY2017 Financial Results Reported; Considerable Operational Runway; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Strong Cash Position and Pipeline Progress Makes for an Attractive Setup
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Shares Remain Attractively Priced as Lead Pipeline Programs Progress
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Initiating at OUTPERFORM; You Are What You Eat: Engineered Bugs to the Rescue
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D